Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir and what is the scope of freedom to operate?
Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. There are seventeen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Dasabuvir sodium; ombitasvir, paritaprevir, ritonavir has six hundred and twenty-one patent family members in fifty-four countries.
Summary for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
| International Patents: | 621 |
| US Patents: | 17 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
US Patents and Regulatory Information for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Expired US Patents for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
| Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
| Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
| Abbvie | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir, paritaprevir, ritonavir | TABLET;ORAL | 206619-001 | Dec 19, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Cyprus | 1115893 | ⤷ Try a Trial | |
| Argentina | 077411 | FORMA DE DOSIFICACION FARMACEUTICA SOLIDA, CON LOPINAVIR Y RITONAVIR, Y PROCESO PARA SU PREPARACION. | ⤷ Try a Trial |
| China | 101842360 | Anti-infective pyrimidines and uses thereof | ⤷ Try a Trial |
| Taiwan | 201600087 | Methods for treating HCV | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2368890 | 2015/010 | Ireland | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/14/982 20150115 |
| 2203431 | 300729 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR OF ZOUT DAARVAN, WAARONDER DASABUVIR NATRIUMMONOHYDRAAT; REGISTRATION NO/DATE: EU/1/14/983 20150119 |
| 2692346 | 2017/046 | Ireland | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REGISTRATION NO/DATE: EU/1/17/1213 20170726 |
| 2340029 | 92667 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: PARITAPREVIR, OU UN SEL OU ESTER PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE (VIEKIRAX). FIRST REGISTRATION: 20150119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
